HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells.
about
Statins for age-related macular degenerationHydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsisStatins for age-related macular degenerationStatins for age-related macular degenerationRisk factors in coronary atherosclerosis athero-inflammation: the meeting pointAtorvastatin reduces lipopolysaccharide-induced expression of cyclooxygenase-2 in human pulmonary epithelial cells.Statins for age-related macular degenerationPotential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic NephropathyAntioxidants, inflammation and cardiovascular diseaseStatins as regulators of redox state in the vascular endothelium: beyond lipid loweringRepurposing Treatments to Enhance Innate Immunity. Can Statins Improve Neutrophil Functions and Clinical Outcomes in COPD?Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesDose-specific effect of simvastatin on hypoxia-induced HIF-1α and BACE expression in Alzheimer's disease cybrid cells.Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell diseaseHeme-mediated cell activation: the inflammatory puzzle of sickle cell anemia.HuR regulates the expression of stress-sensitive genes and mediates inflammatory response in human umbilical vein endothelial cells.Preadmission statin use and one-year mortality among patients in intensive care - a cohort study.Statins and delirium during critical illness: a multicenter, prospective cohort study.Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditionsNitric oxide (NO)-releasing statin derivatives, a class of drugs showing enhanced antiproliferative and antiinflammatory properties.Statins, the renin-angiotensin-aldosterone system and hypertension - a tale of another beneficial effect of statins.Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cellsStatins: cardiovascular risk reduction in percutaneous coronary intervention-basic and clinical evidence of hyperacute use of statins.Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with α-interferon and ribavirin: Rosuvastatin reduces NAFLD in HCV patients.The many roles of statins in ischemic strokeAmlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy.Rosuvastatin reduces neointima formation in a rat model of balloon injury.Statins Inhibit Fibrillary β-Amyloid Induced Inflammation in a Model of the Human Blood Brain Barrier.Statins: immunomodulators for autoimmune rheumatic disease?Anti-inflammatory effects of statins: clinical evidence and basic mechanisms.Differential metabolic actions of specific statins: clinical and therapeutic considerationsThe association of prior statin use in septic shock treated with early goal directed therapy.Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: an ancillary study to a randomised controlled trial.Statins and the vascular endothelial inflammatory responseVaricose Remodeling of Veins Is Suppressed by 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors.Use of lipid-lowering agents for the prevention of age-related macular degeneration: a meta-analysis of observational studies.Simvastatin: two decades in a circle.Inflammation during obesity is not all bad: evidence from animal and human studies.Increases in creatine kinase with atorvastatin treatment are not associated with decreases in muscular performanceSimvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers
P2860
Q24188161-81BD9E9D-4CAE-40AB-9B75-4D7F22FD8A45Q24193361-C509769C-1798-4154-94FA-075579A8BDDBQ24201178-0E45865F-2F07-4F91-A37B-99BC16F0F151Q24240102-3C6F1BCC-489C-47E3-A1B4-332A4EA30F66Q24793107-E9C01C7B-8A73-446C-A887-4CDAF00D0AA8Q24796446-612465E1-40FB-46D9-A009-080A52200514Q26470515-491E215C-1AAD-4744-9858-54E7ECA1E56FQ26784039-E2982050-F040-43F4-A924-9DA267DD9A38Q26823009-3318ABEB-5D4E-4FA6-8B93-4A40E45D1EE2Q26853120-009B4637-1A68-4C2D-82F8-C6FF24DE5AB7Q28066773-0C9B717C-78CA-4BC5-9EFE-A6401EE9E348Q28388335-07A02672-B3BC-4899-A637-DAD55625AEDFQ30371544-FD9E0ECF-4952-4572-B99D-D0AA7CC815AEQ30492867-C7984C0B-704C-4BAE-BBFB-5315040A9123Q33365378-EFA46DC2-55C6-49CF-83CA-0ECA202DE189Q33859593-E7062AED-284A-4FB4-9C5C-1B4434FF644CQ33919029-48E345B0-60F5-466F-88D1-2262517D9FBEQ33921904-FDF9821C-5736-4677-AAB0-D24050E46D62Q34217461-100AE742-A06C-4793-8BBA-5B63035434DDQ34376402-1A94FADB-6574-4D0D-836C-257EF2AC369EQ34429685-9E34B5BB-3294-4F42-84D4-34F09639D81DQ34696107-B8CD1B65-415D-4F04-AF33-DF6E7161C94AQ34729472-5AD00B8D-8441-4598-8A60-DF69CD6E7A5DQ35507354-202AE6C0-B226-42A3-A581-95591A5F82BCQ35595431-F2857C7F-2259-4140-BA6B-7D6EE7B18389Q35680633-65920340-F378-49C5-9B9E-546656507BFEQ35961612-ED5F2086-7C2D-49BD-A1A1-9F968F6E652BQ36054103-090BEDD7-A37F-4EF6-844D-D3C08B30F0A9Q36088044-CE78D402-D600-4061-BEAB-5AD4058D6B71Q36337932-C9676AB3-12B5-4158-82B9-A85F947BB01BQ36406951-E0D32CB2-C295-4D39-9FA9-4D13803B7EB4Q36566297-1AFBDBFC-D9A8-455C-BD23-ABE2ABAA9831Q36689726-CB1C4EE3-2D64-4C59-B4FB-BB7005047443Q36695979-6D716C56-D839-4503-97DC-1A26275ACDA4Q36714057-82EB402C-BEA6-466A-A68C-32D39B99D87EQ37045695-CBECE5CC-A42A-465B-9BCF-59A45BFDF237Q37165690-B5E4B377-89AC-4FFE-9066-9E20C3F2E20FQ37174503-FEAAC646-6174-441F-9F29-037D3D0BBDBDQ37189927-2C8B363F-962C-46CA-862B-F9E4828E23BEQ37225099-82C50430-85C1-4665-A3D9-7934CC927DA4
P2860
HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
HMG-CoA reductase inhibitors r ...... vascular smooth muscle cells.
@en
type
label
HMG-CoA reductase inhibitors r ...... vascular smooth muscle cells.
@en
prefLabel
HMG-CoA reductase inhibitors r ...... vascular smooth muscle cells.
@en
P2093
P1476
HMG-CoA reductase inhibitors r ...... vascular smooth muscle cells.
@en
P2093
Franz Weidinger
Hannes F Alber
Jan Nilsson
Jozef Dulak
Matthias Frick
Mikko P S Ares
Otmar Pachinger
Severin P Schwarzacher
Wolfgang Dichtl
P356
10.1161/01.ATV.0000043456.48735.20
P407
P577
2003-01-01T00:00:00Z